Skip to Content


In the US, Darunavir (darunavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Treatment of HIV infection

Chemical Names


((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-metylpropyl)amino)-2-hydroxy-1-(phenylmetyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester

(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-1-benzyl-2-hydroxy-3-(N¹-isobutylsulfanilamido)propyl]carbamate (WHO)

Foreign Names

  • Darunavirum (Latin)
  • Darunavir (German)
  • Darunavir (French)
  • Darunavir (Spanish)

Generic Names

  • Darunavir (OS: USAN, BAN)
  • TMC-114 (IS: Tibotec)
  • UIC 94017 (IS)
  • Darunavir Ethanolate (OS: JAN)
  • TMC 114 (IS: Tibotec)

Brand Names

  • Prezista
    Janssen, Brazil; Janssen, Canada; Janssen, Chile; Janssen, Hong Kong; Janssen, Malaysia; Janssen, Singapore; Janssen, Slovakia; Janssen, Thailand; Janssen, Taiwan; Janssen Cilag, Argentina; Janssen-Cilag, Ecuador; Janssen-Cilag, Greece; Janssen-Cilag, Lithuania; Janssen-Cilag, Oman; Johnson & Johnson, Turkey; Xian Janssen, China
  • REZOLSTA (Darunavir and Cobicistat)
    Janssen-Cilag International NV, Slovenia; Johnson & Johnson, Croatia (Hrvatska)
  • Prezcobix (Darunavir and Cobicistat)
    Janssen Pharma, United States
  • Prezista
    Haemato Pharm, Austria; Inopha, Austria; Janssen, Australia; Janssen, Finland; Janssen, Hungary; Janssen, Ireland; Janssen, Norway; Janssen, New Zealand; Janssen, Romania; Janssen Cilag, Netherlands; Janssen Cilag, Serbia; Janssen Pharma, United States; Janssen Pharmaceutical, Japan; Janssen-Cilag, Belgium; Janssen-Cilag, Switzerland; Janssen-Cilag, Colombia; Janssen-Cilag, Czech Republic; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, United Kingdom; Janssen-Cilag, Israel; Janssen-Cilag, Italy; Janssen-Cilag, Latvia; Janssen-Cilag, Poland; Janssen-Cilag, Portugal; Janssen-Cilag International, Austria; Johnson & Johnson, Croatia (Hrvatska); Pharmacare, South Africa; Tibotec, United States; Janssen, Iceland
    Janssen-Cilag, Germany
  • Prezistanaive
    Janssen Pharmaceutical, Japan
  • REZOLSTA (Darunavir and Cobicistat)
    Janssen, Ireland; Janssen-Cilag, United Kingdom


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.